Diabetic retinopathy management guidelines
Abstract
Diabetic retinopathy (DR) is an important cause of avoidable blindness worldwide. Seventy percent of diabetes occur in low and lower-middle income countries. Clinical practice guidelines for the management of DR have been implemented throughout the world, but mainly in developed nations. However, there is considerable variation between existing guidelines in the recommended frequency of referral, methods for examination and personnel involved in screening and review. This review compares the differences between current available guidelines in the context of the current medical evidence and also addresses the implications for management of DR in countries with limited resources.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
UK and Australia recommendations suggested a minimum sensitivity of either 80% or 60%, and a specificity of at least 95%.
“In the UK and Australia, previous recommendations suggested a minimum sensitivity of either 80% or 60%, and a specificity of at least 95%25–30.”
From Economic evaluation for medical artificial intelligence: accuracy vs. cost-effectiveness in a diabetic retinopathy screening case (2024) · cites this paper as [29]
Cites
Effects of medical therapies on retinopathy progression in type 2 diabetes
The ACCORD Study Group and ACCORD Eye Study Group (2010) · New England Journal of Medicine · doi:10.1056/nejmoa1001288 · Cited by 1,311 · see citing works
Diabetes Prevention Program Research Group (2007) · Diabetic Medicine · doi:10.1111/j.1464-5491.2007.02043.x · Cited by 363 · see citing works
Progression of diabetic retinopathy in pregnancy: association with hypertension in pregnancy
Rosenn, B., Miodovnik, M., Kranias, G., Khoury, J., Combs, C. A., Mimouni, F., Siddiqi, T. A., & Lipman, M. J. (1992) · American Journal of Obstetrics and Gynecology · doi:10.1016/s0002-9378(11)90608-5 · Cited by 169 · see citing works
Jovanovic, L., Metzger, B. E., Knopp, R. H., conley, M. R., Park, E., Lee, Y. J., Simpson, J. L., Holmes, L., Aarons, J. H., & Mills, J. L. (1998) · Diabetes Care · doi:10.2337/diacare.21.11.1978 · Cited by 129 · see citing works
Pregnancy-induced sight-threatening diabetic retinopathy in women with type 1 diabetes
Vestgaard, M., Ringholm, L., Laugesen, C. S., Rasmussen, K. L., Damm, P., & Mathiesen, E. R. (2010) · Diabetic Medicine · doi:10.1111/j.1464-5491.2010.02958.x · Cited by 121 · see citing works
Vitrectomy in the management of diabetic retinopathy
Smiddy, W. E., & Flynn, H. W. (1999) · Survey of Ophthalmology · doi:10.1016/s0039-6257(99)00036-3 · Cited by 114 · see citing works
C-Reactive Protein, Diabetes, and Attendance at Religious Services
King, D. E., Mainous, A. G., & Pearson, W. S. (2002) · Diabetes Care · doi:10.2337/diacare.25.7.1172 · Cited by 105 · see citing works
Flagged first, then by citations
Cited by
Sorted by citations
Gulshan, V., Peng, L., Coram, M., Stumpe, M. C., Wu, D., Narayanaswamy, A., Venugopalan, S., Widner, K., Madams, T., Cuadros, J., et al. (2016) · JAMA · doi:10.1001/jama.2016.17216 · Cited by 7,697 · see citing works
Ting, D. S. W., Cheung, C. Y.-L., Lim, G., Tan, G. S. W., Quang, N. D., Gan, A., Hamzah, H., Garcia-Franco, R., San Yeo, I. Y., Lee, S. Y., et al. (2017) · JAMA · doi:10.1001/jama.2017.18152 · Cited by 2,402 · see citing works
Sayres, R., Taly, A., Rahimy, E., Blumer, K., Coz, D., Hammel, N., Krause, J., Narayanaswamy, A., Rastegar, Z., Wu, D., et al. (2019) · Ophthalmology · doi:10.1016/j.ophtha.2018.11.016 · Cited by 418 · see citing works
Gulshan, V., Rajan, R. P., Widner, K., Wu, D., Wubbels, P., Rhodes, T., Whitehouse, K., Coram, M., Corrado, G., Ramasamy, K., et al. (2019) · JAMA Ophthalmology · doi:10.1001/jamaophthalmol.2019.2004 · Cited by 303 · see citing works
Ruamviboonsuk, P., Krause, J., Chotcomwongse, P., Sayres, R., Raman, R., Widner, K., Campana, B. J. L., Phene, S., Hemarat, K., Tadarati, M., et al. (2019) · npj Digital Medicine · doi:10.1038/s41746-019-0099-8 · Cited by 233 · see citing works
Bhaskaranand, M., Ramachandra, C., Bhat, S., Cuadros, J., Nittala, M. G., Sadda, S. R., & Solanki, K. (2019) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2019.0164 · Cited by 211 · see citing works
Li, J. Q., Welchowski, T., Schmid, M., Letow, J., Wolpers, C., Pascual-Camps, I., Holz, F. G., & Finger, R. P. (2020) · European Journal of Epidemiology · doi:10.1007/s10654-019-00560-z · Cited by 179 · see citing works
Wang, Y., Liu, C., Hu, W., Luo, L., Shi, D., Zhang, J., Yin, Q., Zhang, L., Han, X., & He, M. (2024) · npj Digital Medicine · doi:10.1038/s41746-024-01032-9 · Cited by 76 · see citing works
- Authors
- Chakrabarti, R., Harper, C. A., & Keeffe, J. E.
- Affiliations
- The University of Melbourne (AU)
- Venue
- Expert Review of Ophthalmology
- Publisher
- Informa UK Limited
- Published
- 2012-10
- Volume
- 7
- Issue
- 5
- Pages
- 417-439
- ISSN
- 1746-9899 (ISSN-L)
- 1746-9902
- OpenAlex
- W1984639731
- Cited by
- 112
- References
- 7
- Citations by year
- 2026: 5 · 2025: 5 · 2024: 14 · 2023: 17 · 2022: 19 · 2021: 12 · 2020: 8 · 2019: 9 · 2018: 5 · 2017: 6 · 2016: 3 · 2015: 2 · 2014: 6 · 2013: 1
- FWCI
- 2.70
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Expert Review of Ophthalmology (publishedVersion)
- Topics
- Health Sciences › Medicine › Ophthalmology › Retinal Diseases and Treatments
- Health Sciences › Medicine › Radiology, Nuclear Medicine and Imaging › Retinal Imaging and Analysis
- Health Sciences › Medicine › Radiology, Nuclear Medicine and Imaging › Retinal and Macular Surgery
- Keywords
- diabetic retinopathy, guideline comparison, blindness prevention, diabetes mellitus, low- and middle-income countries, retinal screening, screening frequency, resource-limited settings
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
